135 related articles for article (PubMed ID: 31536667)
21. Epidermal growth factor receptor (EGFR), HER2 and insulin-like growth factor-1 receptor (IGF-1R) status in ovarian adult granulosa cell tumours.
Higgins PA; Brady A; Dobbs SP; Salto-Tellez M; Maxwell P; McCluggage WG
Histopathology; 2014 Apr; 64(5):633-8. PubMed ID: 24206174
[TBL] [Abstract][Full Text] [Related]
22. Post-operative complications of salvage total laryngectomy forpost-radiotherapy recurrent laryngeal cancer using pectoralis major myocutaneous flaps.
Okamoto I; Tsukahara K; Shimizu A; Sato H
Acta Otolaryngol; 2019 Feb; 139(2):167-171. PubMed ID: 30794035
[TBL] [Abstract][Full Text] [Related]
23. A novel glycoengineered bispecific antibody format for targeted inhibition of epidermal growth factor receptor (EGFR) and insulin-like growth factor receptor type I (IGF-1R) demonstrating unique molecular properties.
Schanzer JM; Wartha K; Croasdale R; Moser S; Künkele KP; Ries C; Scheuer W; Duerr H; Pompiati S; Pollman J; Stracke J; Lau W; Ries S; Brinkmann U; Klein C; Umana P
J Biol Chem; 2014 Jul; 289(27):18693-706. PubMed ID: 24841203
[TBL] [Abstract][Full Text] [Related]
24. IGF-1R associates with adverse outcomes after radical radiotherapy for prostate cancer.
Aleksic T; Verrill C; Bryant RJ; Han C; Worrall AR; Brureau L; Larré S; Higgins GS; Fazal F; Sabbagh A; Haider S; Buffa FM; Cole D; Macaulay VM
Br J Cancer; 2017 Nov; 117(11):1600-1606. PubMed ID: 28972962
[TBL] [Abstract][Full Text] [Related]
25. Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3/AKT signaling pathway: rational basis for cotargeting insulin-like growth factor-1 receptor and epidermal growth factor receptor in hepatocellular carcinoma.
Desbois-Mouthon C; Baron A; Blivet-Van Eggelpoël MJ; Fartoux L; Venot C; Bladt F; Housset C; Rosmorduc O
Clin Cancer Res; 2009 Sep; 15(17):5445-56. PubMed ID: 19706799
[TBL] [Abstract][Full Text] [Related]
26. Salvage laryngectomy after radical radiotherapy for laryngeal carcinoma.
Crellin RP; Gaze MN; White A; Maran AG; MacDougall RH
Clin Otolaryngol Allied Sci; 1992 Oct; 17(5):449-51. PubMed ID: 1458631
[TBL] [Abstract][Full Text] [Related]
27. Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells.
Song RX; Zhang Z; Chen Y; Bao Y; Santen RJ
Endocrinology; 2007 Aug; 148(8):4091-101. PubMed ID: 17525128
[TBL] [Abstract][Full Text] [Related]
28. [Expression and significance of IGF-IR and PKC in laryngeal squamous cell carcinoma].
Liu J; Pan S; Zhou Y; Yu Z; Liu L
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Feb; 24(4):152-5. PubMed ID: 20422977
[TBL] [Abstract][Full Text] [Related]
29. [Treatment and prognosis of stage III-IV laryngeal squamous cell carcinoma].
Tian WD; Zeng ZY; Chen FJ; Wu GH; Guo ZM; Zhang Q
Ai Zheng; 2006 Jan; 25(1):80-4. PubMed ID: 16405756
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of EGF receptor expression in early glottic cancer.
Demiral AN; Sarioglu S; Birlik B; Sen M; Kinay M
Auris Nasus Larynx; 2004 Dec; 31(4):417-24. PubMed ID: 15571917
[TBL] [Abstract][Full Text] [Related]
31. Impact of IGF-1R/EGFR cross-talks on hepatoma cell sensitivity to gefitinib.
Desbois-Mouthon C; Cacheux W; Blivet-Van Eggelpoël MJ; Barbu V; Fartoux L; Poupon R; Housset C; Rosmorduc O
Int J Cancer; 2006 Dec; 119(11):2557-66. PubMed ID: 16988945
[TBL] [Abstract][Full Text] [Related]
32. Supracricoid laryngectomy with cricohyoidopexy for recurrence of early-stage glottic carcinoma after irradiation. Long-term oncological and functional results.
Marchese-Ragona R; Marioni G; Chiarello G; Staffieri A; Pastore A
Acta Otolaryngol; 2005 Jan; 125(1):91-5. PubMed ID: 15799582
[TBL] [Abstract][Full Text] [Related]
33. Expression of miR-296-5p as predictive marker for radiotherapy resistance in early-stage laryngeal carcinoma.
Maia D; de Carvalho AC; Horst MA; Carvalho AL; Scapulatempo-Neto C; Vettore AL
J Transl Med; 2015 Aug; 13():262. PubMed ID: 26264462
[TBL] [Abstract][Full Text] [Related]
34. High mTOR expression is associated with a worse oncological outcome in laryngeal carcinoma treated with postoperative radiotherapy: a pilot study.
Lionello M; Blandamura S; Loreggian L; Ottaviano G; Giacomelli L; Marchese-Ragona R; Velardita C; Staffieri A; Marioni G
J Oral Pathol Med; 2012 Feb; 41(2):136-40. PubMed ID: 21943204
[TBL] [Abstract][Full Text] [Related]
35. Stomal recurrence in patients with T1 glottic cancer after salvage laryngectomy for radiotherapy failures: role of p53 overexpression and subglottic extension.
Reddy SP; Narayana A; Melian E; Kathuria S; Leman C; Emami B
Am J Clin Oncol; 2001 Apr; 24(2):124-7. PubMed ID: 11319283
[TBL] [Abstract][Full Text] [Related]
36. Combination of anti-IGF-1R antibody A12 and ionizing radiation in upper respiratory tract cancers.
Riesterer O; Yang Q; Raju U; Torres M; Molkentine D; Patel N; Valdecanas D; Milas L; Ang KK
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1179-87. PubMed ID: 21129859
[TBL] [Abstract][Full Text] [Related]
37. [Radiotherapy of supraglottic cancers. Report on 84 patients].
Notter G; Sandberg N; Turesson I; Heikel P
HNO; 1984 Nov; 32(11):460-6. PubMed ID: 6511500
[TBL] [Abstract][Full Text] [Related]
38. Long-term observations and salvage operations on patients with T2N0M0 squamous cell carcinoma of the glottic larynx treated with radiation therapy alone.
Furusaka T; Matuda H; Saito T; Katsura Y; Ikeda M
Acta Otolaryngol; 2012 May; 132(5):546-51. PubMed ID: 22264025
[TBL] [Abstract][Full Text] [Related]
39. Insulin-like growth factor receptor-1 overexpression is associated with poor response of rectal cancers to radiotherapy.
Wu XY; Wu ZF; Cao QH; Chen C; Chen ZW; Xu Z; Li WS; Liu FK; Yao XQ; Li G
World J Gastroenterol; 2014 Nov; 20(43):16268-74. PubMed ID: 25473182
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and Prognostic Value of HPV among Tunisian Patients with Laryngeal Cancer and Relationship between DNA HPV and p16, IGF-1R, Survivin, p53 Expressions.
Ben Elhadj M; Fourati A; El Amine O; Goucha A; El May A; El May MV; Mokni Baizig N
Ann Otol Rhinol Laryngol; 2020 Sep; 129(9):863-871. PubMed ID: 32364419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
